» Articles » PMID: 16484093

Premorbid Intellectual Functioning and Risk of Schizophrenia and Spectrum Disorders

Overview
Publisher Routledge
Date 2006 Feb 18
PMID 16484093
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Evidence from longitudinal studies indicates that lower IQ score in childhood and early adolescence increases risk of schizophrenia and schizophrenia spectrum disorders (SSD). This study investigated the association between premorbid IQ and risk of SSD in a population-based cohort of 17-year-old conscripts. Fifty four thousand males assessed by the Israeli Draft Board during two consecutive years were followed by means of the Israeli National Psychiatric Hospitalization Case Registry for up to 11 years. Tests of verbal and non-verbal reasoning, mathematical knowledge and instructions comprehension and several psychosocial variables were recorded by the Draft Board. Risk for SSD increased with decreasing IQ score. Only poorer non-verbal reasoning conferred a significant increased risk for SSD after taking into account general intellectual ability. IQ was not associated with age of onset. These results confirm the importance of low intellectual functioning as a risk factor for SSD. This is unlikely to be due to prodrome.

Citing Articles

Effects of Toxoplasma gondii infection on cognition, symptoms, and response to digital cognitive training in schizophrenia.

Guimaraes A, Coelho D, Scoriels L, Mambrini J, Antonelli L, Henriques P Schizophrenia (Heidelb). 2022; 8(1):104.

PMID: 36434103 PMC: 9700796. DOI: 10.1038/s41537-022-00292-2.


The Behavioral Mapping of Psychomotor Slowing in Psychosis Demonstrates Heterogeneity Among Patients Suggesting Distinct Pathobiology.

Nadesalingam N, Lefebvre S, Alexaki D, Gama D, Wuthrich F, Kyrou A Schizophr Bull. 2022; 49(2):507-517.

PMID: 36413085 PMC: 10016403. DOI: 10.1093/schbul/sbac170.


Prevalence and correlates of cognitive impairment in schizophrenia: a cross-sectional study from a teaching hospital southern Sri Lanka.

Goonathilake P, Ediriweera D, Ruban R, Isuru A BMC Psychiatry. 2022; 22(1):716.

PMID: 36397028 PMC: 9670486. DOI: 10.1186/s12888-022-04368-2.


Dispersion of cognitive performance test scores on the MATRICS Consensus Cognitive Battery: A different perspective.

Williamson D, Nuechterlein K, Tishler T, Ventura J, Ellingson B, Turkoz I Schizophr Res Cogn. 2022; 30:100270.

PMID: 36111288 PMC: 9468588. DOI: 10.1016/j.scog.2022.100270.


Antipsychotic Drug Development: From Historical Evidence to Fresh Perspectives.

Weston-Green K Front Psychiatry. 2022; 13:903156.

PMID: 35782443 PMC: 9243257. DOI: 10.3389/fpsyt.2022.903156.